Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/35qyoM5
via IFTTT